Study of Adolescent Immunization Recall Systems
NCT01390363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420
Last updated 2017-04-13
Summary
The purpose of this study is to determine whether contacting the parents of adolescents overdue for routine vaccines or contacting both the parents AND adolescents overdue to routine vaccines improves immunization rates as compared to usual care.
Conditions
- Immunization
- Reminder Systems
Interventions
- OTHER
-
Parent Only Phone Call
A telephone call will be made to the parent/guardian informing them that the adolescent has not received one or more vaccines (Td/Tdap in the past 5 years, the MCV4 vaccine, or the 2nd VZV vaccine). The phone call will include a brief informational statement about the vaccine(s) that the adolescent has not yet received. Up to 4 telephone calls will be attempted. As part of the phone call, we will offer to schedule an appointment for the adolescent to receive the missing immunization(s). We will also ask them to mail or fax to the Adolescent/Young Adult Medicine clinic records of immunizations given at other sites.
- OTHER
-
Parent and Adolescent Phone Call
A telephone call will be made to the parent/guardian informing them that the adolescent has not received one or more vaccines (Td/Tdap in the past 5 years, the MCV4 vaccine, or the 2nd VZV vaccine). The phone call will include a brief informational statement about the vaccine(s) that the adolescent has not yet received. Up to 4 telephone calls will be attempted. As part of the phone call, we will offer to schedule an appointment for the adolescent to receive the missing immunization(s). We will also ask them to mail or fax to the Adolescent/Young Adult Medicine clinic records of immunizations given at other sites. We will also ask permission to speak with the adolescent as well, and if granted, will make up to 4 phone calls to the adolescent to convey the same message.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kathryn S Brigham, MD · Boston Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 13 Years
- Max Age
- 17 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-01
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 ·Status: COMPLETED ·Phase: NA
-
Adolescent Vaccination Kiosk Project
NCT01622608 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Reminders to Complete HPV Series
NCT01731496 ·Status: COMPLETED ·Phase: NA
-
Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344 ·Status: COMPLETED
-
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
NCT01362322 ·Status: COMPLETED ·Phase: PHASE4
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
NCT01439165 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755 ·Status: RECRUITING ·Phase: PHASE1
-
A School Health Center Intervention to Increase Adolescent Vaccination
NCT01595542 ·Status: COMPLETED ·Phase: NA
-
Understanding Typhoid Disease After Vaccination
NCT01405521 ·Status: COMPLETED ·Phase: PHASE2
-
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
NCT00319553 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
NCT01629589 ·Status: COMPLETED ·Phase: PHASE4
-
A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine
NCT00109330 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
NCT00514059 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults
NCT03541499 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation With Bordetella Pertussis Using Controlled Human Infection
NCT06903221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
NCT02118961 ·Status: COMPLETED ·Phase: PHASE3
-
School Located Adolescent Vaccination Study
NCT01719679 ·Status: COMPLETED ·Phase: NA
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED
-
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
NCT01661751 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
NCT00610168 ·Status: COMPLETED ·Phase: PHASE4
-
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease
NCT00282295 ·Status: COMPLETED ·Phase: PHASE4